Given that there were 46% patients with atrial fibrillation (AF), which is known to increase cardiac biomarkers including cardiac troponin and NT‐proBNP 20, 21, we additionally studied the tumour biomarker levels, stratified by the absence of AF. This evidence concerns the gene NPPB and neoplasm.